Pain burden in desmoid tumor patients: A survey of the French Advocacy Group SOS Desmoid

被引：18

作者：

Rigaux, Philippe ^{[1
]}

Lefebvre-Kuntz, Daniele ^{[2
]}

Penel, Nicolas ^{[1
,3
]}

机构：

[1] SOS Desmoide, F-49100 Angers, France

[2] Ctr Oscar Lambret, Pain Clin & Anesthesiol Dept, F-59020 Lille, France

[3] Ctr Oscar Lambret, Dept Gen Oncol, F-59020 Lille, France

来源：

BULLETIN DU CANCER | 2015年 / 102卷 / 03期

关键词：

Pain; Desmoid tumor; Aggressive fibromatosis; Burden; PROGNOSTIC-FACTORS; PHASE-II; CHEMOTHERAPY; SERIES;

D O I：

10.1016/j.bulcan.2015.02.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Introduction > The French Patient Advocacy Group SOS Desmoid conducted a survey to measure the pain burden of desmoid tumor patients. Material and methods > We used a structured questionnaire to measure the occurrence and consequences of pain. Results > The pain occurrence was approximately 63%. In one-third of the cases, the pain was permanent. This pain led to severe social and economic consequences. Discussion > The occurrence of pain and its consequences are underestimated among these patients. Pain needs to be closely and precisely measured and monitored in future clinical trials to assess the efficacy of proposed treatments better.

引用

页码：213 / 216

页数：4

共 50 条

[31] NONCYTOTOXIC DRUG-THERAPY FOR INTRAABDOMINAL DESMOID TUMOR IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS
TSUKADA, K
CHURCH, JM
JAGELMAN, DG
FAZIO, VW
MCGANNON, E
GEORGE, CR
SCHROEDER, T
LAVERY, I
OAKLEY, J
DISEASES OF THE COLON & RECTUM, 1992, 35 (01) : 29 - 33
[32] Maintaining Health-related Quality of Life for Desmoid Tumor Patients The Proof is in the Data
Roland, Christina L.
ANNALS OF SURGERY, 2023, 277 (06) : 884 - 885
[33] Prognostic factors of abdominal desmoid tumor after surgery: A retrospective study of 52 patients
Zheng, Qingfen
Liu, Bingrong
Zhou, Yangyang
Liu, Dan
ASIAN JOURNAL OF SURGERY, 2022, 45 (09) : 1770 - 1771
[34] A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients
Dumont, A. G.
Rink, L.
Godwin, A. K.
Miettinen, M.
Joensuu, H.
Strosberg, J. R.
Gronchi, A.
Corless, C. L.
Goldstein, D.
Rubin, B. P.
Maki, R. G.
Lazar, A. J.
Lev, D.
Trent, J. C.
von Mehren, M.
ANNALS OF ONCOLOGY, 2012, 23 (05) : 1335 - 1340
[35] Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group
Crombe, Amandine
Kind, Michele
Ray-Coquard, Isabelle
Isambert, Nicolas
Chevreau, Christine
Andre, Thierry
Lebbe, Celeste
Le Cesne, Axel
Bompas, Emmanuelle
Piperno-Neumann, Sophie
Saada, Esma
Bouhamama, Amine
Blay, Jean-Yves
Italiano, Antoine
AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (06) : 1539 - 1548
[36] Pegylated liposomal doxorubicin (PLD) as an active treatment option for desmoid tumor (DT) patients.
Pang, Angela
Macedo, Daniela Venancio Gouveia
Carbini, Mariana
Maki, Robert G.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[37] The activity and safety of anlotinib combined with chemotherapy for patients with desmoid tumor: A retrospective study in a single institution
Zhang, P.
Liang, X.
Niu, X.
Gao, S.
Wang, X.
Wang, J.
Yao, W.
ANNALS OF ONCOLOGY, 2022, 33 : S1614 - S1614
[38] Does the Type of Colectomy Modify the Risk of Desmoid Tumor Development in Familial Adenomatous Polyposis Patients?
Wang, Zhen Zhen
Walter, Thomas
Guillaud, Olivier
Cotte, Eddy
Pasquer, Arnaud
Vinet, Olivier
Poncet, Gilles
Ponchon, Thierry
Saurin, Jean-christophe
GASTROENTEROLOGY, 2014, 146 (05) : S864 - S864
[39] Minimally invasive pouch surgery predisposes to desmoid tumor formation in patients with familial adenomatous polyposis (FAP)
Vogel, JD
Church, JM
LaGuardia, L
DISEASES OF THE COLON & RECTUM, 2005, 48 (03) : 662 - 663
[40] MULTI-CENTER PHASE II STUDY OF SUNITINIB IN PATIENTS WITH ADVANCED AGGRESSIVE FIBROMATOSIS (DESMOID TUMOR)
Jo, J.
Kim, K.
Hong, Y. S.
Lee, J.
Lee, J.
Park, Y. S.
Kim, S. Y.
Kim, T. W.
ANNALS OF ONCOLOGY, 2012, 23 : 479 - 479

← 1 2 3 4 5 →